MX378890B - Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados. - Google Patents
Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados.Info
- Publication number
- MX378890B MX378890B MX2018006905A MX2018006905A MX378890B MX 378890 B MX378890 B MX 378890B MX 2018006905 A MX2018006905 A MX 2018006905A MX 2018006905 A MX2018006905 A MX 2018006905A MX 378890 B MX378890 B MX 378890B
- Authority
- MX
- Mexico
- Prior art keywords
- obesity
- treatment
- bifidobacterium longum
- metabolic disorders
- associated metabolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199660 | 2015-12-11 | ||
| PCT/EP2016/080454 WO2017097987A1 (en) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum for treating obesity and associated metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018006905A MX2018006905A (es) | 2018-08-24 |
| MX378890B true MX378890B (es) | 2025-03-10 |
Family
ID=55070675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018006905A MX378890B (es) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10973862B2 (enExample) |
| EP (1) | EP3386523B1 (enExample) |
| JP (1) | JP6843140B2 (enExample) |
| KR (1) | KR102819885B1 (enExample) |
| CN (1) | CN109069552B (enExample) |
| AU (1) | AU2016368527B2 (enExample) |
| BR (1) | BR112018011665A2 (enExample) |
| CA (1) | CA3006176C (enExample) |
| DK (1) | DK3386523T3 (enExample) |
| ES (1) | ES2760076T3 (enExample) |
| MX (1) | MX378890B (enExample) |
| PL (1) | PL3386523T3 (enExample) |
| RU (1) | RU2740096C2 (enExample) |
| WO (1) | WO2017097987A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| US11590179B2 (en) | 2017-02-28 | 2023-02-28 | Precisionbiotics Group Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
| WO2019038449A1 (en) | 2017-08-25 | 2019-02-28 | University College Cork - National University Of Ireland, Cork | USE OF BIFIDOBACTERIUM LONGUM TO TREAT OBESITY AND PERMIT CONTROL OF WEIGHT |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
| KR102156399B1 (ko) * | 2018-04-11 | 2020-09-16 | 한국생명공학연구원 | 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도 |
| JP7811843B2 (ja) | 2018-07-19 | 2026-02-06 | ペンデュラム セラピューティクス， インコーポレイテッド | 微生物生着のための方法および組成物 |
| KR102224072B1 (ko) * | 2019-08-19 | 2021-03-10 | 주식회사 빙그레 | 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도 |
| EP4117697A1 (en) | 2020-03-13 | 2023-01-18 | PrecisionBiotics Group Limited | Bifidobacterium longum |
| CN113564069B (zh) * | 2021-05-28 | 2023-09-29 | 中山大学 | 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用 |
| CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
| BG67720B1 (bg) * | 2022-03-18 | 2025-04-30 | "Ел Би Булгарикум" ЕАД | Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект |
| CN115637237B (zh) * | 2022-09-07 | 2024-09-17 | 辽宁贝克瑞生物科技有限公司 | 一株长双歧杆菌及其应用 |
| CN119073589A (zh) * | 2024-02-07 | 2024-12-06 | 君乐宝乳业集团股份有限公司 | 一种具有促进骨骼健康功能的组合物及其应用 |
| KR102789455B1 (ko) * | 2025-02-05 | 2025-04-04 | 주식회사 리스큐어바이오사이언시스 | 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| RU2473681C2 (ru) * | 2007-03-28 | 2013-01-27 | Элиментари Хелт Лимитед | ПРОБИОТИЧЕСКИЙ ШТАММ Bifidobacterium longum, КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ТАКОЙ ШТАММ, И ЕГО ПРИМЕНЕНИЕ |
| EP2176299B1 (en) * | 2007-05-04 | 2017-07-05 | Alimentary Health Limited | Exopolysaccharide from bifidobacterium infantis 35624 (ncimb 41003) |
| CN102984955B (zh) * | 2008-11-11 | 2015-01-07 | 营养健康有限公司 | 长双歧杆菌 |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| RU2546251C2 (ru) * | 2009-11-11 | 2015-04-10 | Алиментари Хелс Лимитед | Пробиотический штамм бифидобактерий |
| EP3593811A1 (en) * | 2012-09-20 | 2020-01-15 | Prothera, Inc. | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
-
2016
- 2016-12-09 CN CN201680079991.4A patent/CN109069552B/zh active Active
- 2016-12-09 WO PCT/EP2016/080454 patent/WO2017097987A1/en not_active Ceased
- 2016-12-09 KR KR1020187016182A patent/KR102819885B1/ko active Active
- 2016-12-09 MX MX2018006905A patent/MX378890B/es unknown
- 2016-12-09 JP JP2018530515A patent/JP6843140B2/ja active Active
- 2016-12-09 CA CA3006176A patent/CA3006176C/en active Active
- 2016-12-09 RU RU2018119287A patent/RU2740096C2/ru active
- 2016-12-09 US US16/060,765 patent/US10973862B2/en active Active
- 2016-12-09 DK DK16820183.8T patent/DK3386523T3/da active
- 2016-12-09 ES ES16820183T patent/ES2760076T3/es active Active
- 2016-12-09 BR BR112018011665A patent/BR112018011665A2/pt not_active Application Discontinuation
- 2016-12-09 PL PL16820183T patent/PL3386523T3/pl unknown
- 2016-12-09 EP EP16820183.8A patent/EP3386523B1/en active Active
- 2016-12-09 AU AU2016368527A patent/AU2016368527B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3386523B1 (en) | 2019-10-09 |
| WO2017097987A1 (en) | 2017-06-15 |
| RU2018119287A3 (enExample) | 2020-06-30 |
| EP3386523A1 (en) | 2018-10-17 |
| RU2018119287A (ru) | 2020-01-13 |
| BR112018011665A2 (pt) | 2018-12-04 |
| PL3386523T3 (pl) | 2020-03-31 |
| RU2740096C2 (ru) | 2021-01-11 |
| KR20180083352A (ko) | 2018-07-20 |
| CN109069552B (zh) | 2023-01-24 |
| KR102819885B1 (ko) | 2025-06-12 |
| JP6843140B2 (ja) | 2021-03-17 |
| CN109069552A (zh) | 2018-12-21 |
| DK3386523T3 (da) | 2020-01-06 |
| ES2760076T3 (es) | 2020-05-13 |
| CA3006176C (en) | 2023-10-31 |
| MX2018006905A (es) | 2018-08-24 |
| US10973862B2 (en) | 2021-04-13 |
| JP2018536427A (ja) | 2018-12-13 |
| AU2016368527B2 (en) | 2023-01-12 |
| US20190111090A1 (en) | 2019-04-18 |
| AU2016368527A1 (en) | 2018-07-12 |
| CA3006176A1 (en) | 2017-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018006905A (es) | Bifidobacterium longum para el tratamiento de la obesidad y trastornos metabolcos asociados. | |
| CY1122344T1 (el) | Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων | |
| IL291445A (en) | Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders | |
| DK3858977T5 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| CY1122867T1 (el) | Συνθεσεις που περιλαμβανουν ενα βακτηριακο στελεχος του blautia hydrogenotrophica για χρηση στην θεραπεια ή προληψη διαρροιας ή δυσκοιλιοτητας | |
| WO2016086209A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders | |
| EA201990566A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| DK3668972T3 (da) | Konstruerede dnase-enzymer og anvendelse i terapi | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| MX395076B (es) | COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. | |
| MX2017000776A (es) | Polipeptidos fhbp meningococicos modificados. | |
| AU2015352158A8 (en) | Medicaments for slowing Parkinson's Disease | |
| DK3387156T3 (da) | Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme | |
| BR112016023752A2 (pt) | utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose | |
| MX383749B (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas | |
| EP3141254A4 (en) | Lactobacillus rhamnosus rht-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseases | |
| MX2017005249A (es) | Compuestos para usarse en el tratamiento antihelmintico. | |
| EP3682008A4 (en) | GENETICALLY MODIFIED MICRO-ORGANISMS AND THEIR METHODS OF USE | |
| MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
| EP3601525C0 (en) | LACTOBACILLUS CASEI PROBIOTIC STRAIN AND ITS USES | |
| GB201600975D0 (en) | Novel strain of probiotic bacteria and compositions and uses thereof | |
| MX2017001047A (es) | Compuestos para usar en el tratamiento antihelmintico. | |
| IL250450A0 (en) | A new Bacillus type bacterium and its uses | |
| MX383473B (es) | Empleo de probióticos en el incremento de la fertilidad masculina. | |
| PL3197280T3 (pl) | Nowe szczepy bakterii gatunku bacillus amyloliquefaciens i powiązane zastosowania |